[Form 4] Prairie Operating Co. Insider Trading Activity
Rhea-AI Filing Summary
Bryan Freeman, EVP of Operations of Prairie Operating Co. (PROP), reported grants on Form 4. On 08/13/2025 he was granted 585,000 restricted stock units (RSUs) under the company LTIP that vest ratably in three annual installments beginning March 26, 2026, and 585,000 performance units that convert to common stock based on relative total shareholder return over a three-year performance period from 01/01/2025 to 12/31/2027. Following these awards, he beneficially owns 712,861 shares of common stock and 585,000 performance-unit-linked shares, all reported as direct holdings.
Positive
- Alignment of interests: Performance units tie payout to relative total shareholder return, aligning executive incentives with shareholder outcomes
- Retention focus: RSUs vesting over three years support executive retention through staggered vesting
Negative
- Potential dilution: Large aggregate award (1,170,000 units at target) could dilute existing shareholders if issued and vested
- Materiality unknown: Filing lacks grant-value or percent-of-outstanding-share context, limiting assessment of financial impact
Insights
TL;DR: Large time- and performance-based equity grants align an executive with multi-year shareholder returns.
These awards are standard long-term incentive compensation: RSUs vesting over three years provide retention value, while performance units tie ultimate payout to relative total shareholder return, creating pay-for-performance alignment. The scale—585,000 RSUs and 585,000 performance units—is material relative to many mid-cap issuers and may dilute existing shareholders over time if fully issued, but the filing only discloses grant mechanics and current beneficial ownership without valuation or percent-of-common outstanding context.
TL;DR: Filing properly discloses grant dates, vesting schedule, and reporting person relationship; no trading activity reported.
The Form 4 shows acquisitions coded as grants (Transaction Code A) with zero price, reflecting compensation awards rather than open-market transactions. The report includes dates, vesting timeline, and the performance period parameters required for Section 16 transparency. There is no indication of a 10b5-1 plan or sales; the form is a routine disclosure of equity compensation.